"Elraglusib with chemotherapy and immune priming represents a novel sequential therapy approach to treat advanced salivary cancers ... rate among the non-Adenoid Cystic Carcinoma (ACC) population ...

Tiffiney Beard expected a rough road ahead after her April 2024 diagnosis with a rare cancer of the salivary glands. Tumors from adenoid cystic carcinoma target the body’s nerves, so fighting ...

Beard was diagnosed in early 2024 with adenoid cystic carcinoma—a rare, highly invasive and often difficult-to-treat tumor—in her salivary gland. "Managing this type of tumor is very difficult ...

"Elraglusib with chemotherapy and immune priming represents a novel sequential therapy approach to treat advanced salivary cancers. We were encouraged by the response rate among the non-Adenoid Cystic ...

Collaborative efforts through platforms like the Adenoid Cystic Carcinoma Research Foundation (ACCRF) are critical to accelerate clinical trials for rare cancers. Regular imaging follow-up is ...

Adenoid cystic carcinoma (ACC) is a salivary gland tumour that may involve the respiratory tract and can cause symptoms that mimic benign conditions, such as chronic obstructive pulmonary disease and ...

Steen was diagnosed in July 2022 with adenoid cystic carcinoma, a rare and aggressive cancer. After experiencing oral discomfort, she scheduled a dentist appointment, which led to the diagnosis of ...